<qa>  Fatigue, neurobehavioral dysfunction, and quality of life are assessed during theFatigue, neurobehavioral dysfunction, and quality of life are assessed during the randomized phase at baseline and on days 7 and 21 and then during the extended treatment phase at baseline and on days 28 and 56. 